NCT03975764 is a clinical trial of Collection of fecal sample in Gut Microbiome, sponsored by Rambam Health Care Campus.

Who is sponsoring NCT03975764?

NCT03975764 is sponsored by Rambam Health Care Campus.

What drugs are being tested in NCT03975764?

Interventions in NCT03975764: Collection of fecal sample.

What condition does NCT03975764 study?

NCT03975764 studies Gut Microbiome.

Is NCT03975764 still recruiting?

NCT03975764 is currently status unknown. Last updated 5 June 2019.

Last reviewed 2019-06-05 · How we verify

NCT03975764

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fecal Microbiota in Preterm Birth

Status unknown Last updated 5 June 2019

What this trial tests

trial testing Collection of fecal sample in Gut Microbiome in 40 participants. Status unknown.

Timeline

1 October 2019

Primary endpoint
1 May 2020

1 May 2021

Quick facts

Lead sponsor	Rambam Health Care Campus
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	40
Start date	1 October 2019
Primary completion	1 May 2020
Estimated completion	1 May 2021

Drugs / interventions tested

Collection of fecal sample

Conditions studied

Gut Microbiome — all drugs for Gut Microbiome →

Sponsor

Rambam Health Care Campus — full company profile →

Who can join

Adults 18 to 50, female only, with Gut Microbiome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We will compeer fecal microbiome in preterm birth with fecal microbiome of team labor

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gut Microbiome

Currently open trials in the same condition.

NCT07052071 — Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis · recruiting
NCT07225153 — Goat Milk-Derived Formula vs. Undiluted Goat Milk in Infants Unable to Exclusively Breastfeed: Growth and Biomarker Anal · NA · recruiting
NCT07109713 — The Effect Cranberry-Based Products on the Female Microbiome · NA · recruiting
NCT06876935 — Early Avocado Exposure on Development and the Gut Microbiome in American Hispanic Infants · NA · recruiting
NCT07082348 — Feasibility and Potential Efficacy of Herbs and Spices for Improving Dietary Quality in College Students: A Pilot Study · NA · recruiting

Other Rambam Health Care Campus trials

Trials by the same sponsor.

NCT07384013 — Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs · NA · recruiting
NCT06688253 — Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis · Phase 4 · not yet recruiting
NCT06235749 — Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery · NA · recruiting
NCT06622902 — Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants. · NA · recruiting
NCT05922111 — Cervical Ripening Balloon for 12 Hours vs. 1 Hour. · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03975764 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rambam Health Care Campus
Last refreshed: 5 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03975764.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing